Pursuant to Regulation 29 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Medicamen Biotech has informed that the Meeting of the Board of Directors of the Company will be held on Thursday, August 13, 2020 at 1506, Chiranjiv Tower, 43, Nehru Place, New Delhi-110019 to consider the following resolutions: To consider, approve and take on record of Un-audited Financial Results (Standalone & Consolidated) for quarter year ended on June 30, 2020, To consider & approve draft Annual Report for the financial year 2019-20, To consider and approve re-appointment of Harish Pande (DIN: 01575625) as Non-Executive Independent Director of the Company subject to the approval of shareholders at the ensuing Annual General Meeting, To consider and approve re-appointment of Suresh Kumar Singh (DIN: 00318015) as Non-Executive of the Company subject to the approval of shareholders at the ensuing Annual General Meeting and To discuss any other business with the permission of the chair. Further, in accordance with the SEBI (Prevention of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the Company's securities was closed from July 1, 2020 and will open 48 hours after the said Financial Results are declared to stock exchange.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: